 CAMBRIDGE, Mass., March 08, 2022 GLOBE NEWSWIRE -- Sigilon Therapeutics, Inc. NASDAQ: SGTX, a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living TherapeuticsTM platform, today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will present a corporate overview during the Barclays Global Healthcare Conference. The presentation will take place on Tuesday, March 15, 2022 at 10:45 a.m. EDT and will be followed by a 25-minute QA break out session. 